BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 14599868)

  • 21. Surgical treatment and histopathological assessment of advanced cervicovaginal carcinoma: A prospective study and retrospective analysis.
    Höckel M; Wolf B; Hentschel B; Horn LC
    Eur J Cancer; 2017 Jan; 70():99-110. PubMed ID: 27914244
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extended pelvic resections for recurrent or persistent uterine and cervical malignancies: an update on out of the box surgery.
    Andikyan V; Khoury-Collado F; Sonoda Y; Gerst SR; Alektiar KM; Sandhu JS; Bochner BH; Barakat RR; Boland PJ; Chi DS
    Gynecol Oncol; 2012 May; 125(2):404-8. PubMed ID: 22285844
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic factors for curative pelvic exenterations in patients with recurrent uterine cervical or vaginal cancer.
    Sardain H; Lavoué V; Laviolle B; Henno S; Foucher F; Levêque J
    Int J Gynecol Cancer; 2014 Nov; 24(9):1679-85. PubMed ID: 25254565
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical outcome of pelvic exenteration in patients with advanced or recurrent uterine cervical cancer.
    Tanaka S; Nagase S; Kaiho-Sakuma M; Nagai T; Kurosawa H; Toyoshima M; Tokunaga H; Otsuki T; Utsunomiya H; Takano T; Niikura H; Ito K; Yaegashi N
    Int J Clin Oncol; 2014 Feb; 19(1):133-8. PubMed ID: 23404487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Step-by-step demonstration of laparoscopic laterally extended endopelvic resection for a recurrent endometrial cancerous tumor at a sciatic foramen, with a detailed explanation of the pelvic sidewall anatomy.
    Kanao H; Omi M; Takeshima N
    Gynecol Oncol; 2020 Jan; 156(1):260-261. PubMed ID: 31785862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extended lateral pelvic sidewall excision (ELSiE): an approach to optimize complete resection rates in locally advanced or recurrent anorectal cancer involving the pelvic sidewall.
    Shaikh I; Aston W; Hellawell G; Ross D; Littler S; Burling D; Marshall M; Northover JM; Antoniou A; Jenkins JT
    Tech Coloproctol; 2014 Dec; 18(12):1161-8. PubMed ID: 25380742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Outcomes of perisurgery and short-time follow-up of pelvic exenteration for 17 cases with locally recurrent cervical cancer].
    Deng H; Wang JL; Wang ZQ; Li XW; Hu H; Yang B; Zhang XM; Shen K; Guo P; Liang B
    Zhonghua Fu Chan Ke Za Zhi; 2020 Apr; 55(4):259-265. PubMed ID: 32375433
    [No Abstract]   [Full Text] [Related]  

  • 28. Extended pelvic resections for recurrent uterine and cervical cancer: out-of-the-box surgery.
    Caceres A; Mourton SM; Bochner BH; Gerst SR; Liu L; Alektiar KM; Kardos SV; Barakat RR; Boland PJ; Chi DS
    Int J Gynecol Cancer; 2008; 18(5):1139-44. PubMed ID: 18053063
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of recurrent cervical cancer: a review of the literature.
    Peiretti M; Zapardiel I; Zanagnolo V; Landoni F; Morrow CP; Maggioni A
    Surg Oncol; 2012 Jun; 21(2):e59-66. PubMed ID: 22244884
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Resectability rates of previously irradiated recurrent cervical cancer (PIRCC) treated with pelvic exenteration: is still the clinical involvement of the pelvis wall a real contraindication? a twenty-year experience.
    Jurado M; Alcázar JL; Martinez-Monge R
    Gynecol Oncol; 2010 Jan; 116(1):38-43. PubMed ID: 19878978
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ultra-radical compartmentalized surgery in gynaecological oncology.
    Höckel M
    Eur J Surg Oncol; 2006 Oct; 32(8):859-65. PubMed ID: 16690243
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pelvic exenteration for recurrent squamous cell carcinoma of the pelvic organs arising from the cloaca--a single institution's experience over 16 years.
    Tan KK; Pal S; Lee PJ; Rodwell L; Solomon MJ
    Colorectal Dis; 2013; 15(10):1227-31. PubMed ID: 23714581
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between developmental steps in the organogenesis of the uterine cervix and locoregional progression of cervical cancer: a prospective clinicopathological analysis.
    Höckel M; Hentschel B; Horn LC
    Lancet Oncol; 2014 Apr; 15(4):445-56. PubMed ID: 24656439
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 'Salvage cytoreductive surgery for pelvic side wall recurrent endometrial cancer: robotic combined laterally extended endopelvic resection (LEER) and laterally extended pelvic resection (LEPR) debulking'.
    Di Donna MC; Cucinella G; Zaccaria G; Laganà AS; Scambia G; Chiantera V
    Int J Gynecol Cancer; 2023 Jan; 33(1):126-127. PubMed ID: 36100283
    [No Abstract]   [Full Text] [Related]  

  • 36. Pelvic exenteration for gynaecological tumours: achievements and unanswered questions.
    Höckel M; Dornhöfer N
    Lancet Oncol; 2006 Oct; 7(10):837-47. PubMed ID: 17012046
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Laterally Extended Pelvic Resection for Gynaecological Malignancies: A Multicentric Experience with Out-of-the-Box Surgery.
    Vizzielli G; Naik R; Dostalek L; Bizzarri N; Kucukmetin A; Tinelli G; Scambia G; Cibula D
    Ann Surg Oncol; 2019 Feb; 26(2):523-530. PubMed ID: 30539489
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aggressive surgical treatment with bony pelvic resection for locally recurrent rectal cancer.
    Uehara K; Ito Z; Yoshino Y; Arimoto A; Kato T; Nakamura H; Imagama S; Nishida Y; Nagino M
    Eur J Surg Oncol; 2015 Mar; 41(3):413-20. PubMed ID: 25477268
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Out-of-the-box pelvic surgery including iliopsoas resection for recurrent gynecological malignancies: Does that make sense? A single-institution case-series.
    Vizzielli G; Chiantera V; Tinelli G; Fagotti A; Gallotta V; Di Giorgio A; Gueli Alletti S; Scambia G
    Eur J Surg Oncol; 2017 Apr; 43(4):710-716. PubMed ID: 27890348
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictors for long-term survival after interdisciplinary salvage surgery for advanced or recurrent gynecologic cancers.
    Fleisch MC; Pantke P; Beckmann MW; Schnuerch HG; Ackermann R; Grimm MO; Bender HG; Dall P
    J Surg Oncol; 2007 May; 95(6):476-84. PubMed ID: 17192947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.